Investigational Treatment Combining TG1050, an HBV-Specific Immunotherapeutic, with Direct Acting Antivirals or Immunomodulators, Improves Sustained Antiviral Effects and Immune Responses in HBV-Persistent Mice
HEPATOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要